DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2209026/c4-cccc-up-6-on-restructuring-plan-to-curb-cash-burn?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209026 Jan 11, 2024 - The new restructuring plan will allow C4 Therapeutics (CCCC) to extend its cash runway into 2027. The company plans to reduce its workforce by nearly 30%. 0

https://www.zacks.com/stock/news/2208771/want-better-returns-don-t-ignore-these-2-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2208771 Jan 11, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. 0

https://www.zacks.com/stock/news/2207561/novo-nordisk-s-nvo-phase-iii-diabetes-study-meets-primary-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207561 Jan 09, 2024 - Novo Nordisk (NVO) reports positive top-line data from one of its late-stage studies under the COMBINE program evaluating once-weekly IcoSema in type II diabetes patients. 0

https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363 Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases. 0

https://www.fool.com/investing/2024/01/04/the-best-stocks-to-invest-1000-in-right-now/?source=iedfolrf0000001 Jan 04, 2024 - It's not too late to get in on these market beaters. 0

https://www.zacks.com/stock/news/2205527/here-s-why-you-should-invest-in-adverum-advm-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205527 Jan 04, 2024 - Here, we discuss some reasons why buying Adverum Biotechnologies (AQST) stock now may turn out to be a prudent move. 0

https://www.zacks.com/stock/news/2205299/novo-nordisk-nvo-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2205299 Jan 03, 2024 - In the closing of the recent trading day, Novo Nordisk (NVO) stood at $103.62, denoting a +1.48% change from the preceding trading day. 0

https://www.fool.com/investing/2024/01/03/missed-out-eli-lilly-best-pharmaceutical-stock/?source=iedfolrf0000001 Jan 03, 2024 - The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead. 0

https://www.zacks.com/stock/news/2205099/here-s-why-you-should-bet-on-rigel-pharmaceuticals-rigl-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205099 Jan 03, 2024 - Here, we discuss some reasons why buying Rigel Pharmaceuticals (RIGL) stock now may turn out to be a prudent move. 0

https://www.zacks.com/stock/news/2204853/here-s-why-you-should-invest-in-aquestive-aqst-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204853 Jan 03, 2024 - Here, we discuss some reasons why buying Aquestive Therapeutics (AQST) stock now may turn out to be a prudent move. 0